These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
884 related articles for article (PubMed ID: 33478794)
1. Immunoinformatics prediction of overlapping CD8 Fatoba AJ; Maharaj L; Adeleke VT; Okpeku M; Adeniyi AA; Adeleke MA Vaccine; 2021 Feb; 39(7):1111-1121. PubMed ID: 33478794 [TBL] [Abstract][Full Text] [Related]
2. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations. Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614 [TBL] [Abstract][Full Text] [Related]
3. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches. Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015 [TBL] [Abstract][Full Text] [Related]
4. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach. Uttamrao PP; Sathyaseelan C; Patro LPP; Rathinavelan T Front Immunol; 2021; 12():692937. PubMed ID: 34497604 [TBL] [Abstract][Full Text] [Related]
6. Landscape and selection of vaccine epitopes in SARS-CoV-2. Smith CC; Olsen KS; Gentry KM; Sambade M; Beck W; Garness J; Entwistle S; Willis C; Vensko S; Woods A; Fini M; Carpenter B; Routh E; Kodysh J; O'Donnell T; Haber C; Heiss K; Stadler V; Garrison E; Sandor AM; Ting JPY; Weiss J; Krajewski K; Grant OC; Woods RJ; Heise M; Vincent BG; Rubinsteyn A Genome Med; 2021 Jun; 13(1):101. PubMed ID: 34127050 [TBL] [Abstract][Full Text] [Related]
7. A vaccine built from potential immunogenic pieces derived from the SARS-CoV-2 spike glycoprotein: A computational approximation. Marchan J J Immunol Methods; 2022 Mar; 502():113216. PubMed ID: 35007561 [TBL] [Abstract][Full Text] [Related]
8. Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein. Chukwudozie OS; Gray CM; Fagbayi TA; Chukwuanukwu RC; Oyebanji VO; Bankole TT; Adewole RA; Daniel EM PLoS One; 2021; 16(3):e0248061. PubMed ID: 33730022 [TBL] [Abstract][Full Text] [Related]
9. T and B cell Epitope analysis of SARS-CoV-2 S protein based on immunoinformatics and experimental research. Chen Z; Ruan P; Wang L; Nie X; Ma X; Tan Y J Cell Mol Med; 2021 Jan; 25(2):1274-1289. PubMed ID: 33325143 [TBL] [Abstract][Full Text] [Related]
10. Exploring the S Protein of SARS-CoV-2 to Design a Novel Multi-Epitope Vaccine against COVID-19 Based on Immunoinformatics Approaches. Huang Z; Shi H; Gong H; Sun Q; Yang S; Zhang Y; Shi Z; Xia Z; Huang S; Yao S; Xu F Front Biosci (Landmark Ed); 2024 May; 29(5):196. PubMed ID: 38812300 [TBL] [Abstract][Full Text] [Related]
11. Overlapping CD8+ and CD4+ T-cell epitopes identification for the progression of epitope-based peptide vaccine from nucleocapsid and glycoprotein of emerging Rift Valley fever virus using immunoinformatics approach. Adhikari UK; Rahman MM Infect Genet Evol; 2017 Dec; 56():75-91. PubMed ID: 29107145 [TBL] [Abstract][Full Text] [Related]
12. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study. Yang Z; Bogdan P; Nazarian S Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334 [TBL] [Abstract][Full Text] [Related]
13. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2. Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841 [TBL] [Abstract][Full Text] [Related]
14. Immuno-informatics approach for B-cell and T-cell epitope based peptide vaccine design against novel COVID-19 virus. Singh J; Malik D; Raina A Vaccine; 2021 Feb; 39(7):1087-1095. PubMed ID: 33478787 [TBL] [Abstract][Full Text] [Related]
15. A Proteome-Wide Immunoinformatics Tool to Accelerate T-Cell Epitope Discovery and Vaccine Design in the Context of Emerging Infectious Diseases: An Ethnicity-Oriented Approach. Oyarzun P; Kashyap M; Fica V; Salas-Burgos A; Gonzalez-Galarza FF; McCabe A; Jones AR; Middleton D; Kobe B Front Immunol; 2021; 12():598778. PubMed ID: 33717077 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects. Zhao J; Wang L; Schank M; Dang X; Lu Z; Cao D; Khanal S; Nguyen LN; Nguyen LNT; Zhang J; Zhang Y; Adkins JL; Baird EM; Wu XY; Ning S; Gazzar ME; Moorman JP; Yao ZQ Virus Res; 2021 Oct; 304():198508. PubMed ID: 34329696 [TBL] [Abstract][Full Text] [Related]
17. Construction and efficacy testing of DNA vaccines containing HLA-A*02:01-restricted SARS-CoV-2 T-cell epitopes predicted by immunoinformatics. Tan D; Kang N; Zhu Y; Hou J; Wang H; Xu H; Zu C; Gao Z; Liu M; Liu N; Deng Q; Lu H; Liu J; Xie Y Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(7):986-996. PubMed ID: 38655616 [TBL] [Abstract][Full Text] [Related]